The results have expanded our understanding of the effects of many types of breast cancer cells, including TNBC, HER2+, luminal A and luminal B as well as drug-resistant breast cancer cells on mature adipocytes and vice versa in the tumor microenvironment. This evidence concerns the gene ERBB2 and breast cancer.